Volterra Technologies’s Gilead Sciences GILD Stock Holding History

Volterra Technologies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	+9,800	New	+$1.29M	0.18%	120

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Volterra Technologies's GILD Position: Q4 2025 in Review

Volterra Technologies sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,279 shares — an estimated $364K sold.

Volterra Technologies first reported a position in GILD in Q3 2025 and held it in 1 quarter. The position peaked at $364K in Q3 2025. 2,221 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Volterra Technologies reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
Volterra Technologies sold 3,279 Gilead Sciences shares in Q4 2025, an estimated $364K.
Volterra Technologies first reported a position in Gilead Sciences in Q3 2025 and held it in 1 quarter.
Volterra Technologies's Gilead Sciences position peaked at $364K in Q3 2025.
2,221 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Volterra Technologies's 13F filing for Q4 2025, filed 13 Feb 2026.